CA 125 Elevation: A Descriptive Etiological Study
Journal Title: National Journal of Laboratory Medicine - Year 2016, Vol 5, Issue 1
Abstract
Introduction: CA 125 (Cancer/Carbohydrate antigen 125) is a surface antigen expressed mostly by the ovarian cancer cells. Hence, it is widely used as a tumour marker for detection and monitoring the progression of such cancers. CA 125 is also expressed by cells of different tissues such as pleura, pericardium, Mullerian epithelium, peritoneum etc. Objective: To identify the different causes leading to elevation of CA 125 and to estimate the elevation of CA 125 in ovarian and non-ovarian causes. Materials and Methods: A total of 1800 patients testing for CA 125 during the time period January 2011 to December 2013in Kasturba Medical College constituent hospitals, Mangalore were screened. Out of these, OPD patients and in-patients with CA 125 < 35 U/mL were excluded and remaining 236 in-patients were included as the study subjects. Patients were categorized into four groups based on CA 125 level as Group I(35 – 200 U/mL), Group II (201 – 500 U/mL), Group III (501 – 1000 U/mL) and Group IV (>1000 U/mL). To find association of CA 125 with age, patients were stratified into 3 groups based on their age as Group A (15- 35 years), Group B (36-55 years) and Group C (≥ 56 years). Parameters like age, BP, hemoglobin, CA 125,renal profile and diagnosis of all the patients were evaluated. Results: Out of 236 patients 54.7% were suffering from malignant ovarian diseases, 31.3% benign ovarian disease, 12% non-gynecological diseases and 2% from gynecological diseases of non-ovarian origin. Mean age for malignancies was 55 ± 10.6 years for benign diseases was 34±12.7 years. Incidence of malignancy among the 4 groups (based on CA 125 level) was 34.4%, 48.8%, 68.7% and 91.6% respectively. Increase in both age and CA 125 levels was highly significant in patients suffering from ovarian malignancies when compared to those with benign ovarian diseases (p<0.001).Difference in CA 125 levels was also statistically significant between malignant and non gynaecological disorders and between benign ovarian and non gynaecological disorders as well (p<0.001). Conclusion: In spite of higher levels of CA 125 in ovarian carcinoma cases compared to other diagnosis in our data, results confirm the high false positive rate and non-specificity associated with CA 125 as a biomarker as it was seen to increase in numerous other diseases.
Authors and Affiliations
Dr. Shaheena Appan Parambath, Dr. Charu Yadav, Dr. Madan Gopal Ranjan, Dr Anupama Hegde, Dr. Ashok Prabhu, Dr. Poornima Ajay Manjrekar, Dr. Rukmini Mysore Srikantiah
Keywords
Related Articles
- EP ID EP378487
- DOI 10.7860/NJLM/2016/14984:2087
- Views 126
- Downloads 0
Evaluation of Immunoreactivity of p53 in Colorectal Adenocarcinomas
Introduction: Colorectal Cancer (CRC) is regarded as one of the most widespread malignant tumor in the world. The p53 tumor suppressor gene is the most commonly mutated gene in human cancers and is a frequent abnormality...
Isolated Langerhans Cell Histiocytosis of Thyroid-Masquerading as a Thyroid Neoplasm - A Rare Case Report
ABSTRACT Langerhans Cell Histiocytosis (LCH) is a rare neoplastic disease of unknown etiology characterized by oligoclonal proliferation of langerhans cells with a varying incidence rate of 4-5.4 per 1 million individual...
Serum Calcium and Magnesium levels in Pre-eclampsia
Introduction: Pre-eclampsia (PE) is a disorder of pregnancy characterised by hypertension with proteinuria after 20 weeks of pregnancy in previously normotensive and non-proteinuric patients which may progress to seizure...
Neonatal HyperbilirubinemiaEvaluation of Total Calcium, Ionised Calcium, Magnesium, Lactate and Electrolytes
Introduction: A total serum bilirubin level above 5 mg/dL in neonates is defined as neonatal hyperbilirubinemia. In the first week of life around 60% of term and 80% of preterm babies develop jaundice, and at 1 month abo...
Prevalence of Hepatitis A Virus and Hepatitis E Virus in Western Thar Region
Introduction: Hepatitis A Virus (HAV) and Hepatitis E Virus (HEV) pose major health problems in India. Both viruses are enterically transmitted, resulting in Acute Viral Hepatitis (AVH) in developing countries. This stud...